›Supportive bundle
›NPO status
›Oral meds held unless essential
›Aspiration risk reduction
›IV fluids
›0.9% sodium chloride 500-1000 ml bolus
›Repeat bolus based on perfusion and urine output
›Electrolyte correction
›Potassium chloride IV 10 mmol/hour via peripheral line
›Magnesium sulfate IV 2 g over 1 hour if low
›Antiemetics
›Ondansetron IV 4 mg
›Repeat 4 mg every 6-8 hours as needed
Gastric and colonic decompression
›Decompression strategy
›Nasogastric tube
›Persistent vomiting
›Significant distention
›Rectal tube consideration
›Distal colonic decompression attempt in selected cases
›Avoid if suspected perforation
›Pain control
›Fentanyl IV 25-50 micrograms
›Repeat every 5-10 minutes to effect
›Caution with hypotension and respiratory depression
›Hydromorphone IV 0.2-0.5 mg
›Repeat every 10-15 minutes to effect
›Lower starting dose in older adults
›Acetaminophen IV 1 g
›Maximum 4 g/day
›Lower maximum in liver disease
›Broad-spectrum coverage indications
›Suspected ischemia
›Lactate elevation or CT ischemia signs
›Severe continuous pain pattern
›Suspected perforation
›Free air or peritonitis
›Sepsis physiology
›Preoperative prophylaxis pathway
›Timing within 60 minutes of incision when operative
›Redose if prolonged surgery per protocol
›Empiric regimens
›Piperacillin-tazobactam IV 4.5 g
›Repeat every 6-8 hours
›Renal dose adjustment
›Ceftriaxone IV 2 g
›Metronidazole IV 500 mg
›Metronidazole repeat every 8 hours
›Ertapenem IV 1 g
›Once daily dosing
›Option for beta-lactam allergy patterns based on local guidance
Definitive management by etiology
›Malignant obstruction
›Surgical management options
›Resection with primary anastomosis in selected stable patients
›Diverting stoma in unstable or high-risk anastomosis
›Endoscopic stent consideration
›Bridge to surgery in selected left-sided malignant obstruction
›Palliative intent for unresectable disease
›Diverticular stricture or inflammatory stricture
›Operative pathway
›Resection strategy planning
›Diversion consideration if contamination or instability
›Sigmoid volvulus
›Endoscopic detorsion if no peritonitis
›Flexible sigmoidoscopy decompression
›Rectal tube placement post-detorsion
›Surgery if failed endoscopic decompression or ischemia
›Resection and diversion options
›High recurrence risk without definitive surgery
›Cecal volvulus
›Surgical management as primary approach
›Right hemicolectomy consideration
›Cecopexy in selected cases
Thromboprophylaxis and supportive inpatient care
›VTE prophylaxis
›Enoxaparin SC 40 mg daily
›Dose adjustment in renal impairment
›Hold for active bleeding or urgent procedure per protocol
›Mechanical prophylaxis
›Intermittent pneumatic compression devices
›Early mobilization when feasible
Evidence and guideline signals
›Evidence-based positioning
›Class I recommendation based on consensus for urgent surgery in peritonitis or perforation physiology
›Class IIa recommendation based on guideline consensus for endoscopic decompression in uncomplicated sigmoid volvulus
›ACEP Level C style evidence framing for lactate and CT ischemia signs as escalation triggers